Tradestie Institutional Equity Comparison Engine

IONX vs ACB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACB Overall Edge

ACB Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aurora Cannabis Inc. Common Shares (ACB) driven by superior Valuation, Growth & Margin, Momentum & Technical while IONX counters with relative strength in Options & Structure. Fundamentally, IONX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ACB at 109.9x Forward P/E and -13.8% operating margin (-8.8% YoY). In options structure, IONX sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro) against ACB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACB
IONX N/M vs ACB 109.9x Fwd P/E
Growth & Margin Winner ACB
Op Margin N/A vs -13.8% ยท YoY N/A vs -8.8%
Momentum & Technical Winner ACB
1Y -84.5% vs +5.0% ยท 52W Pos 0% vs 54%
Options & Structure Winner IONX
UNCLASSIFIED (4th %ile IV) vs CONSOLIDATION (6th %ile IV)
IONX NASDAQ
Defiance Daily Target 2X Long IONQ ETF
Institutional Equity
$8.27
-16.55% 1D
Market Cap N/A
1M Return -36.82%
1Y Return -84.51%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 45.0 Fund 51.0 Flow 50.0 Mom 64.0
ACB NASDAQ
Aurora Cannabis Inc. Common Shares
Medicinal Chemicals & Botanical Products
$4.61
-6.68% 1D
Market Cap $324.8M
1M Return +15.54%
1Y Return +5.01%
Forward P/E 109.9x
Unified AI Score
40.1 / 100 SELL
Tech 15.0 Fund 40.0 Flow 61.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IONX -84.51% ACB +5.01% Spread: +89.52 pp (ACB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IONX TTM Op. Margin: N/A ACB TTM Op. Margin: -13.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IONX vs ACB. Trailing 12-month operating profitability (IONX N/A vs ACB -13.8%) and valuation multiples (IONX N/M vs ACB 109.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IONX (1) vs ACB (9)
Institutional Metric IONX ACB Criterion Row Winner
Market Capitalization Scale N/A $324.8M Larger Scale ACB
Trailing P/E Ratio Valuation N/M 109.9x Lower Multiple ACB
Forward P/E Ratio Valuation N/M 109.9x Lower Multiple ACB
Revenue Growth (YoY) Growth N/A -8.8% Higher Growth ACB
Operating Margin (TTM) Profitability N/A -13.8% Higher Margin ACB
Net Profit Margin Profitability N/A -38.2% Higher Margin ACB
Return on Equity (ROE) Capital Efficiency N/A -9.4% Higher ROE ACB
52-Week Range Position Momentum 0% ($8โ€“$108) 54% ($3โ€“$6) Stronger Trend ACB
Beta / 30D Volatility Risk Regime 6.79ฮฒ ยท 232% Vol 1.07ฮฒ ยท 87% Vol Lower Realized Risk ACB
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite IONX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IONX vs ACB Buy Guide
IONX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live IONX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACB CONSOLIDATION
29d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IONX nor ACB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.